Jeffrey L. Cummings
UNLV
Jeffrey L. Cummings is listed as UNLV. Jeffrey is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 18 March 2027.
Compiled from published conference agendas; not yet confirmed by Jeffrey. Is this you? Claim this profile.
About
Jeffrey Cummings, MD, ScD(HC), is the Joy Chambers-Grundy Professor of Brain Science, Director of the Chambers-Gundy Center for Transformative Neuroscience and Co-Director of the Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas (UNLV). Dr. Cummings is a Neurologist and is globally recognized for his contributions to Alzheimer’s research, drug development, and clinical trials. He leads the UNLV Clinical Trials Observatory that studies all drugs in current clinical trials for Alzheimer's disease to better inform drug development decisions. Dr. Cummings directs the Biomarker Observatory and is Co-Director of the Alzheimer’s Disease and Related Dementia’s Innovation Incubator. Dr. Cummings has been honored with the Henderson Award of the American Geriatrics Society, Distinguished Scientist Award of the American Association of Geriatric Psychiatry, Leadership and Achievement Award by the Internatio
Upcoming
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- OPTIMISING THERAPY: PROMISING COMBINATION STRATEGIES IN AD AND PD Moderator · 18 March 2027
- THE NEXT ERA OF AD TREATMENT Moderator · 18 March 2027